Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 1
1996 2
1997 4
1998 8
1999 9
2000 7
2001 8
2002 2
2003 4
2004 3
2005 7
2006 1
2007 1
2008 6
2009 3
2010 5
2011 4
2012 6
2013 2
2014 5
2015 11
2016 10
2017 8
2018 3
2019 4
2020 3
2021 4
2022 5
2023 4
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

127 results

Results by year

Filters applied: . Clear all
Page 1
Nintedanib in Progressive Fibrosing Interstitial Lung Diseases.
Flaherty KR, Wells AU, Cottin V, Devaraj A, Walsh SLF, Inoue Y, Richeldi L, Kolb M, Tetzlaff K, Stowasser S, Coeck C, Clerisme-Beaty E, Rosenstock B, Quaresma M, Haeufel T, Goeldner RG, Schlenker-Herceg R, Brown KK; INBUILD Trial Investigators. Flaherty KR, et al. Among authors: tetzlaff k. N Engl J Med. 2019 Oct 31;381(18):1718-1727. doi: 10.1056/NEJMoa1908681. Epub 2019 Sep 29. N Engl J Med. 2019. PMID: 31566307 Clinical Trial.
Nintedanib for Systemic Sclerosis-Associated Interstitial Lung Disease.
Distler O, Highland KB, Gahlemann M, Azuma A, Fischer A, Mayes MD, Raghu G, Sauter W, Girard M, Alves M, Clerisme-Beaty E, Stowasser S, Tetzlaff K, Kuwana M, Maher TM; SENSCIS Trial Investigators. Distler O, et al. Among authors: tetzlaff k. N Engl J Med. 2019 Jun 27;380(26):2518-2528. doi: 10.1056/NEJMoa1903076. Epub 2019 May 20. N Engl J Med. 2019. PMID: 31112379 Free article. Clinical Trial.
Trial of Spesolimab for Generalized Pustular Psoriasis.
Bachelez H, Choon SE, Marrakchi S, Burden AD, Tsai TF, Morita A, Navarini AA, Zheng M, Xu J, Turki H, Anadkat MJ, Rajeswari S, Hua H, Vulcu SD, Hall D, Tetzlaff K, Thoma C, Lebwohl MG; Effisayil 1 Trial Investigators. Bachelez H, et al. Among authors: tetzlaff k. N Engl J Med. 2021 Dec 23;385(26):2431-2440. doi: 10.1056/NEJMoa2111563. N Engl J Med. 2021. PMID: 34936739 Clinical Trial.
Return to diving after COVID-19.
Tetzlaff K. Tetzlaff K. Eur J Prev Cardiol. 2022 Jul 20;29(9):e290. doi: 10.1093/eurjpc/zwac066. Eur J Prev Cardiol. 2022. PMID: 35403202 Free PMC article. No abstract available.
Challenges for Clinical Drug Development in Pulmonary Fibrosis.
White ES, Thomas M, Stowasser S, Tetzlaff K. White ES, et al. Among authors: tetzlaff k. Front Pharmacol. 2022 Jan 31;13:823085. doi: 10.3389/fphar.2022.823085. eCollection 2022. Front Pharmacol. 2022. PMID: 35173620 Free PMC article. Review.
Pulmonary Physiology and Medicine of Diving.
Tetzlaff K. Tetzlaff K. Semin Respir Crit Care Med. 2023 Oct;44(5):705-718. doi: 10.1055/s-0043-1770065. Epub 2023 Jun 27. Semin Respir Crit Care Med. 2023. PMID: 37369217
Going to Extremes of Lung Physiology-Deep Breath-Hold Diving.
Tetzlaff K, Lemaitre F, Burgstahler C, Luetkens JA, Eichhorn L. Tetzlaff K, et al. Front Physiol. 2021 Jul 9;12:710429. doi: 10.3389/fphys.2021.710429. eCollection 2021. Front Physiol. 2021. PMID: 34305657 Free PMC article. Review.
Effects of Breath-Hold Deep Diving on the Pulmonary System.
Schipke JD, Lemaitre F, Cleveland S, Tetzlaff K. Schipke JD, et al. Among authors: tetzlaff k. Respiration. 2019;97(5):476-483. doi: 10.1159/000495757. Epub 2019 Feb 15. Respiration. 2019. PMID: 30783070 Review.
A review of asthma and scuba diving.
Tetzlaff K, Muth CM, Waldhauser LK. Tetzlaff K, et al. J Asthma. 2002 Oct;39(7):557-66. doi: 10.1081/jas-120014920. J Asthma. 2002. PMID: 12442945 Review.
127 results